Perinatal depression: Assessment and management

Australian Family Physician

Volumn 35, Issue 9, 2006, Pages 670-673

  Buist, Anne ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSION; FEMALE; HUMAN; MALE; METHODOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PSYCHOLOGICAL ASPECT; PUERPERAL DEPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT; RISK FACTORS;

EID: 33750595988     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dennerstein L, Lehert P, Riphagen F. Postpartum depression: risk factors. J Psychosom Obstet Gynaecol 1989;(Suppl)10:53-65.
2. O'Hara M, Swain A. Rates and risks of postpartum depression: a meta-analysis. Int Rev Psychiatry 1996;8:37-54.
3. Steiner M. Perinatal mood disorders: Position Paper. Psychopharmacol Bull 1998;34:301-6.
4. Robertson E, Grace S, Wallington T, Stewart D. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004;26:289-95.
5. Beck C. A meta-analysis of predictors of postpartum depression. Nurs Res 1996;45:297-303.
6. Boyce P, Parker G, Barnett B, Connery M, Smith F. Personality as a vulnerability factor to depression. Br J Psychiatry 1991;159:106-14.
7. Buist A. Childhood abuse, postpartum depression and parenting difficulties: a literature review of associations. Aust N Z J Psychiatry 1998;32:370-8.
8. O'Connor T, Ben-Shlomo Y, Heron J, Golding J, Adam D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005;58:211-7.
9. Glover V, O'Connor TG. Effects of antenatal stress and anxiety. Br J Psychiatry 2002;180:389-91.
10. Wadhwa P. Psychoneuroendocrine processes in human pregnancy influencing fetal development and health. Psychoneuroendocrinol 2005;30:724-43.
11. Appleby L. Suicide during pregnancy and in the first postnatal year. BMJ 1991;302:137-40.
12. King JF, Slaytor EK, Sullivan EA. Maternal deaths in Australia 1997-1999. Med J Aust 2004;181:413-4.
13. Victorian Child Death Review Committee Findings. Group Analysis Report Summary: partnerships in caring for children. 2006; Ch 6.
14. Spinelli M. Neonaticide: a systematic investigation of 17 cases. In: Infanticide. Psychosocial and legal perspectives on mothers who kill. Spinelli M, editor. American Psychiatry Press 2003;105-18.
15. Murray L, Cooper P. Postpartum depression and child development. Psychol Med 1997;27:253-60.
16. Murray L, Cooper P. Effects of postnatal depression on infant development. Arch Dis Child 1997;77:99-101.
17. Lumley J, Austin M. What interventions may reduce postpartum depression?. Curr Opin Obstet Gynecol 2001;13:605-11.
18. Buist AE, Condon J, Brooks J, et al. Acceptability of routine screening for postnatal depression. J Affect Disord 2006;93:233-7.
19. Dennis CL. Treatment of postpartum depression: Part 2. A clinical review of nonbiological interventions. J Clin Psych 2004;9:1252-64.
20. Buist A, Bilszta J, Barnett B, et al. Recognition and management of perinatal depression in general practice: a survey of GPs and postnatal women. Aust Fam Physician 2005;34:787-90.
21. Dennis C-L, Stewart D. Treatment of postpartum depression: Part 1. A critical review of biological interventions. J Clin Psych 2004;65:1242-51.
22. Wogelius R, Norgaard M, Muft Munk E, et al. Maternal use of selective serotonin reuptake inhibitors and risk of adverse pregnancy outcomes. Pharmacoepidemiol Drug Saf 2005;14:S143.
23. Chambers C, Johnson K, Dick L, Felix R, Lyons-Jones K. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
24. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonine reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87.
25. Sanz EJ, De-las-Cuevas C, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482-7.
26. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998;45:459-62.